3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Lung Neoplasms
4
Stomach Neoplasms
3
Uterine Cervical Neoplasms
1
Smoking
1
Recurrence
1
Pulmonary Disease, Chronic Obstructive
1
Platelet Glycoprotein IV Deficiency
1
Pediatric Brain Tumor
1
Pancreatic Cyst
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neoplasms
1
Melanoma
1
Lymphoma
1
Locally Advanced Pancreatic Cancer
1
Gastrointestinal Neoplasms
1
Fatty Liver
1
Cysts
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Anus Neoplasms
1
Adenocarcinoma
1
Interventions
Blood Specimen Collection
38
pembrolizumab
36
Bevacizumab
22
Surveys and Questionnaires
18
Standard of Care
18
Radiotherapy
18
Exercise
17
Carboplatin
16
Nivolumab
15
atezolizumab
14
Cisplatin
14
Drug Therapy
13
Paclitaxel
12
Fluorouracil
12
Cyclophosphamide
12
Cetuximab
12
Trastuzumab
10
Leucovorin
10
Docetaxel
10
Dexamethasone
10
Pemetrexed
9
Oxaliplatin
9
Biopsy
9
pertuzumab
8
olaparib
8
Temozolomide
8
Panitumumab
8
Observation
8
Irinotecan
8
abemaciclib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplasms
×
Tomography, X-Ray Computed
×
Clear all
NCT06867172
2025-03-10
SPACE
Carol Davila University of Medicine and Pharmacy
Recruiting
66 enrolled